CCAAT/enhancer binding protein α (C/EBPα) in adipose tissue regulates genes in lipid and glucose metabolism and a genetic variation in C/EBPα is associated with serum levels of triglycerides

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 12, 2008, Pages 4880-4886

  Olofsson, Louise E ^a   Orho Melander, Marju ^b   William Olsson, Lena ^c   Sjöholm, Kajsa ^a   Sjöström, Lars ^a   Groop, Leif ^b   Carlsson, Björn ^a,c   Carlsson, Lena M S ^a   Olsson, Bob ^a,d  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ACYLTRANSFERASE; ADIPONECTIN; ATP BINDING CASSETTE D2; CCAAT ENHANCER BINDING PROTEIN ALPHA; CD36 ANTIGEN; DIACYLGLYCEROL ACYLTRANSFERASE 1; DIACYLGLYCEROL ACYLTRANSFERASE 2; HEXOKINASE; HEXOKINASE 2; HYDROXYSTEROID DEHYDROGENASE; HYDROXYSTEROID DEHYDROGENASE 11 BETA 1; LIPOPROTEIN LIPASE; LONG CHAIN FATTY ACID COENZYME A LIGASE; MESSENGER RNA; UNCLASSIFIED DRUG;

ADENOVIRUS; ADIPOSE TISSUE; ADULT; ARTICLE; CALORIC RESTRICTION; CELL STRAIN 3T3; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DNA POLYMORPHISM; FEMALE; FINLAND; GENE CONTROL; GENE EXPRESSION; GENETIC VARIABILITY; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; LIPID METABOLISM; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 57349119903     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0574     Document Type: Article

References (40)

1. Graves BJ, Johnson PF, McKnight SL 1986 Homologous recognition of a promoter domain common to the MSV LTR and the HSV tk gene. Cell 44:565-576
2. Lekstrom-Himes J, Xanthopoulos KG 1998 Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 273:28545-28548
3. Landschulz WH, Johnson PF, Adashi EY, Graves BJ, McKnight SL 1988 Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev 2:786-800
4. Freytag SO, Paielli DL, Gilbert JD 1994 Ectopic expression of the CCAAT/enhancer-binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev 8:1654-1663
5. Lin FT, Lane MD 1994 CCAAT/enhancer binding protein α is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA 91:8757-8761
6. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, Wilde MD, Taylor LR, Wilson DR, Darlington GJ 1995 Impaired energy homeostasis in C/EBP α knockout mice. Science 269:1108-1112
7. Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL 1989 Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev 3:1146-1156
8. Antonson P, Xanthopoulos KG 1995 Molecular cloning, sequence, and expression patterns of the human gene encoding CCAAT/enhancer binding protein α (C/EBP α). Biochem Biophys Res Commun 215:106-113
9. Inoue Y, Inoue J, Lambert G, Yim SH, Gonzalez FJ 2004 Disruption of hepatic C/EBPα results in impaired glucose tolerance and age-dependent hepatosteatosis. J Biol Chem 279:44740-44748
10. Matsusue K, Gavrilova O, Lambert G, Brewer Jr HB, Ward JM, Inoue Y, LeRoith D, Gonzalez FJ 2004 Hepatic CCAAT/enhancer binding protein α mediates induction of lipogenesis and regulation of glucose homeostasis in leptin-deficient mice. Mol Endocrinol 18:2751-2764
11. Constance CM, Morgan 4th JI, Umek RM 1996 C/EBPα regulation of the growth-arrest-associated gene gadd45. Mol Cell Biol 16:3878-3883
12. Dixon TM, Daniel KW, Farmer SR, Collins S 2001 CCAAT/enhancer-binding protein α is required for transcription of the β 3-adrenergic receptor gene during adipogenesis. J Biol Chem 276:722-728
13. Gout J, Tirard J, Thevenon C, Riou JP, Begeot M, Naville D 2006 CCAAT/enhancer-binding proteins (C/EBPs) regulate the basal and cAMP-induced transcription of the human 11β-hydroxysteroid dehydrogenase encoding gene in adipose cells. Biochimie (Paris) 88:1115-1124
14. Hemati N, Ross SE, Erickson RL, Groblewski GE, MacDougald OA 1997 Signaling pathways through which insulin regulates CCAAT/enhancer binding protein α (C/EBPα) phosphorylation and gene expression in 3T3-L1 adipocytes. Correlation with GLUT4 gene expression. J Biol Chem 272:25913-25919
15. Hollenberg AN, Susulic VS, Madura JP, Zhang B, Moller DE, Tontonoz P, Sarraf P, Spiegelman BM, Lowell BB 1997 Functional antagonism between CCAAT/enhancer binding protein-α and peroxisome proliferator-activated receptor-γ on the leptin promoter. J Biol Chem 272:5283-5290
16. Hwang CS, Mandrup S, MacDougald OA, Geiman DE, Lane MD 1996 Transcriptional activation of the mouse obese (ob) gene by CCAAT/enhancer binding protein α. Proc Natl Acad Sci USA 93:873-877
17. Qiao L, Maclean PS, Schaack J, Orlicky DJ, Darimont C, Pagliassotti M, Friedman JE, Shao J 2005 C/EBPα regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 54:1744-1754
18. Payne VA, Au WS, Gray SL, Nora ED, Rahman SM, Sanders R, Hadaschik D, Friedman JE, O'Rahilly S, Rochford JJ 2007 Sequential regulation of diacylglycerol acyltransferase 2 expression by CAAT/enhancer-binding protein β (C/EBPβ) and C/EBPα during adipogenesis. J Biol Chem 282:21005-21014
19. Behre CJ, Gummesson A, Jernas M, Lystig TC, Fagerberg B, Carlsson B, Carlsson LM 2007 Dissociation between adipose tissue expression and serum levels of adiponectin during and after diet-induced weight loss in obese subjects with and without the metabolic syndrome. Metabolism 56:1022-1028
20. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H 2004 Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351:2683-2693
21. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lonroth H, Naslund I, Olbers T, Stenlof K, Torgerson J, Agren G, Carlsson LM 2007 Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 357:741-752
22. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissen M, Ehrnstrom BO, Forsen B, Isomaa B, Snickars B, Taskinen MR 1996 Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45:1585-1593
23. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M 2001 Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29:365-371
24. Gabrielsson BG, Olofsson LE, Sjogren A, Jernas M, Elander A, Lonn M, Rudemo M, Carlsson LM 2005 Evaluation of reference genes for studies of gene expression in human adipose tissue. Obes Res 13:649-652
25. Friedman AD, Landschulz WH, McKnight SL 1989 CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes Dev 3:1314-1322
26. Edvardsson U, Ljungberg A, Linden D, William-Olsson L, Peilot-Sjogren H, Ahnmark A, Oscarsson J 2006 PPARα activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes. J Lipid Res 47:329-340
27. Olsson B, Andersson PO, Jernas M, Jacobsson S, Carlsson B, Carlsson LM, Wadenvik H 2003 T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med 9:1123-1124
28. Olsson B, Bohlooly YM, Brusehed O, Isaksson OG, Ahren B, Olofsson SO, Oscarsson J, Tornell J 2003 Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes. Am J Physiol Endocrinol Metab 285:E504-E511
29. 2005 A haplotype map of the human genome. Nature 437:1299-1320
30. Brem RB, Yvert G, Clinton R, Kruglyak L 2002 Genetic dissection of transcriptional regulation in budding yeast. Science 296:752-755
31. Cheung VG, Conlin LK, Weber TM, Arcaro M, Jen KY, Morley M, Spielman RS 2003 Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 33:422-425
32. Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, Colinayo V, Ruff TG, Milligan SB, Lamb JR, Cavet G, Linsley PS, Mao M, Stoughton RB, Friend SH 2003 Genetics of gene expression surveyed in maize, mouse and man. Nature 422:297-302
33. Dubois SG, Heilbronn LK, Smith SR, Albu JB, Kelley DE, Ravussin E 2006 Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. Obesity (Silver Spring) 14:1543-1552
34. Yang X, Enerback S, Smith U 2003 Reduced expression of FOXC2 and brown adipogenic genes in human subjects with insulin resistance. Obes Res 11:1182-1191
35. Yang X, Jansson PA, Nagaev I, Jack MM, Carvalho E, Sunnerhagen KS, Cam MC, Cushman SW, Smith U 2004 Evidence of impaired adipogenesis in insulin resistance. Biochem Biophys Res Commun 317:1045-1051
36. Raclot T, Oudart H 1999 Selectivity of fatty acids on lipid metabolism and gene expression. Proc Nutr Soc 58:633-646
37. Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, Wahlstrand B, Hedner T, Corella D, Tai ES, Ordovas JM, Berglund G, Vartiainen E, Jousilahti P, Hedblad B, Taskinen MR, Newton-Cheh C, Salomaa V, Peltonen L, Groop L, Altshuler DM, Orho-Melander M 2008 Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40:189-197
38. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR 2008 Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40: 161-169
39. Merkel M, Eckel RH, Goldberg IJ 2002 Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 43:1997-2006
40. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, Cho EK, Dallaire S, Freeman JL, Gonzalez JR, Gratacos M, Huang J, Kalaitzopoulos D, Komura D, MacDonald JR, Marshall CR, Mei R, Montgomery L, Nishimura K, Okamura K, Shen F, Somerville MJ, Tchinda J, Valsesia A, Woodwark C, Yang F, Zhang J, Zerjal T, Zhang J, Armengol L, Conrad DF, Estivill X, Tyler-Smith C, Carter NP, Aburatani H, Lee C, Jones KW, Scherer SW, Hurles ME 2006 Global variation in copy number in the human genome. Nature 444:444-454